Inventor
WU YONG-JIN
US45 patents
⚠️ This page may combine multiple inventors who share the name “WU YONG-JIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
22 patentsUS7045551B2May 16, 2006
1-aryl-2-hydroxyethyl amides as potassium channel openers
BRISTOL MYERS SQUIBB CO35 citations92
US7098203B2Aug 29, 2006
Homopiperidine derivatives as NK-1 antagonists
BRISTOL MYERS SQUIBB CO13 citations84
US7138423B2Nov 21, 2006
Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
BRISTOL MYERS SQUIBB CO10 citations74
US6933308B2Aug 23, 2005
Aminoalkyl thiazole derivatives as KCNQ modulators
BRISTOL MYERS SQUIBB CO11 citations74
US6900210B2May 31, 2005
Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
BRISTOL MYERS SQUIBB CO7 citations74
US6831080B2Dec 14, 2004
Cinnamide derivatives as KCNQ potassium channel modulators
BRISTOL MYERS SQUIBB CO11 citations71
US11767322B2Sep 26, 2023
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations70
US7087609B2Aug 8, 2006
3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers
BRISTOL MYERS SQUIBB CO5 citations63
US7494986B2Feb 24, 2009
Cycloalkylamine derivatives as NK-1/SSRI antagonists
BRISTOL MYERS SQUIBB CO4 citations62
US7276631B2Oct 2, 2007
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
BRISTOL MYERS SQUIBB CO4 citations62
US7144881B2Dec 5, 2006
Arylcyclopropylcarboxylic amides as potassium channel openers
BRISTOL MYERS SQUIBB CO5 citations62
US7135472B2Nov 14, 2006
3-Heterocyclic benzylamide derivatives as potassium channel openers
BRISTOL MYERS SQUIBB CO4 citations62
US12110290B2Oct 8, 2024
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations61
US8349880B2Jan 8, 2013
Bicyclic compounds for the reduction of beta-amyloid production
BRISTOL MYERS SQUIBB CO4 citations61
US7390925B2Jun 24, 2008
Oxime-containing acyl guanidines as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO5 citations61
US6875771B2Apr 5, 2005
Pyridopyrimidine derivatives as 5-HT6 antagonists
BRISTOL MYERS SQUIBB CO3 citations59
US7476764B2Jan 13, 2009
Phenylcarboxyamides as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US11618753B2Apr 4, 2023
Aminopyrrolotriazines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US7678784B2Mar 16, 2010
Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US7273866B2Sep 25, 2007
2-aryl thiazole derivatives as KCNQ modulators
BRISTOL MYERS SQUIBB CO0 citations41
US10836758B2Nov 17, 2020
Acyl sulfonamide NaV1.7 inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
US9475784B2Oct 25, 2016
4,6-diarylaminothiazines as BACE1 inhibitors and their use for the reduction of beta-amyloid production
BRISTOL MYERS SQUIBB CO0 citations40
PFIZER
13 patentsUS6664238B1Dec 16, 2003
Carbamate and carbazate ketolide antibiotics
PFIZER35 citations92
US6262030B1Jul 17, 2001
Erythromycin derivatives
PFIZER26 citations92
US6300316B1Oct 9, 2001
C-4 substituted macrolide antibiotics
PFIZER25 citations91
US6777543B2Aug 17, 2004
13-methyl erythromycin derivatives
PFIZER16 citations84
US6291656B1Sep 18, 2001
Tricyclic erythromycin derivatives
PFIZER19 citations84
US6159945ADec 12, 2000
9-amino-3-keto erythromycin derivatives
PFIZER18 citations84
US6498146B1Dec 24, 2002
Erythromycin derivatives
PFIZER8 citations74
US6248719B1Jun 19, 2001
Tricyclic 3-keto derivatives of 6-O-methylerthromycin
PFIZER11 citations74
US6162794ADec 19, 2000
Erythromycin derivatives
PFIZER10 citations74
US6258785B1Jul 10, 2001
Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
PFIZER6 citations67
US6825171B2Nov 30, 2004
Erythromycin derivatives
PFIZER5 citations63
US6420343B1Jul 16, 2002
Carbamate and carbazate ketolide antibiotics
PFIZER3 citations63
US6482801B2Nov 19, 2002
9a, 11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin
PFIZER0 citations42
BOY KENNETH M
4 patentsUS8637525B2Jan 28, 2014
Compounds for the reduction of beta-amyloid production
BOY KENNETH M39 citations92
US8486952B2Jul 16, 2013
Compounds for the reduction of β-amyloid production
BOY KENNETH M34 citations91
US8637523B2Jan 28, 2014
Compounds for the reduction of beta-amyloid production
BOY KENNETH M2 citations61
US8710061B2Apr 29, 2014
Compounds for the reduction of β-amyloid production
BOY KENNETH M0 citations40
UNIV VANDERBILT
2 patentsUS10526323B2Jan 7, 2020
Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT2 citations69
US10227343B2Mar 12, 2019
Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT3 citations68